Activation of PVN GLP-1R neurons redistributes T cells and attenuates neuroinflammation

Activation of glucagon-like peptide-1 receptor (GLP-1R) can suppress systemic inflammation, but the underlying mechanisms connecting central GLP-1R signaling to systemic immune cell trafficking are poorly understood. We performed systemic and intracerebroventricular administration of a GLP-1R agonist Exendin-4 (Exn4) with time-resolved flow cytometry, KikGR photoconversion, pharmacological blockade of CXCR4 and glucocorticoid receptors, activity-dependent TRAP2 labeling, and chemogenetic or ablation-based manipulation of paraventricular nucleus of the hypothalamus (PVN) neurons. Functional relevance was assessed in experimental autoimmune encephalomyelitis (EAE). Systemic administration of Exn4 decreased splenic and circulating T-cell abundance, increased bone-marrow T-cell abundance, and increased T-cell surface CXCR4 expression in these compartments. Photoconversion-based tracking of splenic T cells supported enhanced homing to bone marrow. AMD3100 altered the Exn4-associated tissue changes, consistent with a CXCR4-sensitive component. Intracerebroventricular administration of Exn4 raised plasma corticosterone, increased T-cell CXCR4 expression, and reproduced the reciprocal tissue changes. RU486 plus Exn4 differed from Exn4 alone in direct group comparisons, consistent with glucocorticoid receptor involvement. Reactivation of Exn4-responsive PVN neurons and chemogenetic activation of PVN GLP-1R neurons each reproduced the redistribution phenotype. In EAE mice, Exn4 treatment and PVN GLP-1R neuron activation each reduced clinical severity, brain-infiltrating leukocytes, and demyelination. Activation of PVN GLP-1R neurons causes systemic T-cell redistribution and attenuates neuroinflammation. These findings identify a hypothalamic pathway through which GLP-1R signaling can reshape systemic immunity and provide a framework for investigating how metabolic therapeutics influence immune function through the brain.

Authors

Institutions

Publication Details

Journal
Journal of Neuroinflammation
Published
2026-11-17
DOI
https://doi.org/10.1186/s12974-026-04124-3
Primary Topic
Neuroinflammation and Neurodegeneration Mechanisms
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Activation of PVN GLP-1R neurons redistributes T cells and attenuates neuroinflammation

Honglei Ren, Hengchang Xie, Yiwei Fu, Wenqi Liu et al.
1 links
Journal of Neuroinflammation
Neuroinflammation and Neurodegeneration Mechanisms
article

Activation of PVN GLP-1R neurons redistributes T cells and attenuates neuroinflammation

Honglei Ren, Hengchang Xie, Yiwei Fu, Wenqi Liu, Pengfei Liu, 何柏林, Wenjun Zhang, Yingchun Bi, Yingjie Huang, Qiang Liu, Shiqi Wei
article en

Abstract

Activation of glucagon-like peptide-1 receptor (GLP-1R) can suppress systemic inflammation, but the underlying mechanisms connecting central GLP-1R signaling to systemic immune cell trafficking are poorly understood. We performed systemic and intracerebroventricular administration of a GLP-1R agonist Exendin-4 (Exn4) with time-resolved flow cytometry, KikGR photoconversion, pharmacological blockade of CXCR4 and glucocorticoid receptors, activity-dependent TRAP2 labeling, and chemogenetic or ablation-based manipulation of paraventricular nucleus of the hypothalamus (PVN) neurons. Functional relevance was assessed in experimental autoimmune encephalomyelitis (EAE). Systemic administration of Exn4 decreased splenic and circulating T-cell abundance, increased bone-marrow T-cell abundance, and increased T-cell surface CXCR4 expression in these compartments. Photoconversion-based tracking of splenic T cells supported enhanced homing to bone marrow. AMD3100 altered the Exn4-associated tissue changes, consistent with a CXCR4-sensitive component. Intracerebroventricular administration of Exn4 raised plasma corticosterone, increased T-cell CXCR4 expression, and reproduced the reciprocal tissue changes. RU486 plus Exn4 differed from Exn4 alone in direct group comparisons, consistent with glucocorticoid receptor involvement. Reactivation of Exn4-responsive PVN neurons and chemogenetic activation of PVN GLP-1R neurons each reproduced the redistribution phenotype. In EAE mice, Exn4 treatment and PVN GLP-1R neuron activation each reduced clinical severity, brain-infiltrating leukocytes, and demyelination. Activation of PVN GLP-1R neurons causes systemic T-cell redistribution and attenuates neuroinflammation. These findings identify a hypothalamic pathway through which GLP-1R signaling can reshape systemic immunity and provide a framework for investigating how metabolic therapeutics influence immune function through the brain.

Journal of Neuroinflammation
Tianjin Medical University General Hospital (CN), The Affiliated Yongchuan Hospital of Chongqing Medical University (CN), State Key Laboratory of Experimental Hematology (CN), Tianjin Medical University (CN)
National Natural Science Foundation of China
Good health and well-being
Neuroinflammation and Neurodegeneration Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon